-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Dow Jones·03/31/2025 12:30:00

Please log in to view news